Clinical Features, Outcomes, and Biology of EGFR exon 20 Insertions in a Cohort of Hispanic Patients with Non-small Cell Lung Cancer

被引：0

作者：

Motta, R. ^{[1
]}

Cardona, A. ^{[2
]}

Cruz, G. ^{[3
]}

Aliaga, C. ^{[1
]}

Carracedo, C. ^{[1
]}

Raez, L. ^{[4
]}

Arrieta, O. ^{[3
]}

Mezquita, L. ^{[5
]}

Albarran, V. ^{[5
]}

Corrales, L. ^{[6
]}

Bacon, L. ^{[7
]}

Rojas, L.

Zuluaga, J.

Martin, C. ^{[8
]}

Dabalsa, A. ^{[4
]}

Ruiz-Patino, A. ^{[9
]}

Freitas, H. ^{[10
]}

Cordeiro, V. ^{[10
]}

Failoc-Rojas, V. ^{[1
]}

机构：

[1] ALIADA Canc Ctr, Lima, Peru

[2] Luis Carlos Sarmiento Angulo Canc Treatment & Res, Bogota, Colombia

[3] Inst Nacl Cancerol, Mexico City, DF, Mexico

[4] Mem Canc Inst, Hollywood, FL USA

[5] Hosp Clin Barcelona, Barcelona, Spain

[6] CIMCA, San Jose, Costa Rica

[7] Hosp Vivian Pellas, Managua, Nicaragua

[8] Alexander Fleming Inst, Buenos Aires, DF, Argentina

[9] Fdn FICMAC, Bogota, Colombia

[10] AC Camargo Canc Ctr, Sao Paulo, Brazil

来源：

JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期

关键词：

NSCLC; EGFR; Exon20; insertion;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP12.01-61

引用

页码：S666 / S666

页数：1

共 50 条

[11] Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea
Byeon, Seonggyu
Kim, Youjin
Lim, Sung Won
Cho, Jang Ho
Park, Sehoon
Lee, Jiyun
Sun, Jong-Mu
Choi, Yoon-La
Lee, Se-Hoon
Ahn, Jin Seok
Park, Keunchil
Ahn, Myung-Ju
CANCER RESEARCH AND TREATMENT, 2019, 51 (02): : 623 - 631
[12] Clinical characteristics and efficacy in non-small cell lung cancer patients with EGFR exon 20 insertion and EGFR amplification
Gao, X.
Wei, X-W.
Wu, Y-L.
Zhou, Q.
ANNALS OF ONCOLOGY, 2019, 30
[13] VEGFA mediates traditional EGFR-TKI resistance in non-small cell lung cancer with EGFR exon 20 insertions
Yang, Yaning
Liu, Chengming
Yang, Guangjian
Xu, Haiyan
Lei, Siyu
Wang, Yan
CANCER RESEARCH, 2024, 84 (06)
[14] Evaluating the Clinical Characteristics and Prognosis of Advanced Non-Small Cell Lung Cancer with Exon 20 Insertions
Wang, Haibo
Xu, Yiquan
Lin, Jinlan
Huang, Yunjian
CANCER CONTROL, 2024, 31
[15] CLINICAL CHARACTERISTICS OF NON-SMALL CELL LUNG CANCER WITH EGFR GENE MUTATIONS IN EXON 20
Miyanaga, A.
Akagi, K.
Takeuchi, S.
Kurimoto, F.
Iijima, Y.
Yoshino, N.
Mikami, I.
Akiyama, H.
Sakai, H.
LUNG CANCER, 2009, 64 : S54 - S54
[16] Targeting EGFR exon 20 insertions in non-small cell lung cancer by exploiting a dependency on parallel SRC signalling
Vyse, S.
Chen, N.
Oddy, J.
Harrison, P.
Le, A.
Estrada-Bernal, A.
Hermsen, M.
Doebele, R.
Huang, P.
ANNALS OF ONCOLOGY, 2019, 30
[17] EGFR exon 20 insertion mutations in non-small cell lung cancer
Wang, Fenfang
Li, Chenghui
Wu, Qihuan
Lu, Hongyang
TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2982 - 2991
[18] Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer
Brazel, Danielle
Nagasaka, Misako
LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 133 - 138
[19] Unraveling Survival Determinants in Patients with Advanced Non-Small-Cell Lung Cancer with EGFR Exon 20 Insertions
Wang, Kung-Yang
Chang, Shih-Chieh
Wei, Yu-Feng
Hung, Jui-Chi
Chen, Chung-Yu
Chang, Cheng-Yu
CURRENT ONCOLOGY, 2025, 32 (03)
[20] Clinical and real-world outcomes in patients with epidermal growth factor receptor (EGFR) exon 20 insertions in non-small cell lung cancer (NSCLC): A meta-analysis
Tomaras, D.
Lin, H. M.
Forsythe, A.
Crossland, V.
Ou, S-H. I.
ANNALS OF ONCOLOGY, 2020, 31 : S871 - S871

← 1 2 3 4 5 →